Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Avenue Therapeutics Inc. logo

Avenue Therapeutics Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

0.15
 
USD
  
0.00
  
(1.06%)
Optionable: No  Market Cap: 7 M  90-day average vol: 5,455,355

Previous close: 0.151  Open: 0.1554  Bid: 0.152  Ask: 0.1533
52 week range    
0.11   
   1.36
Peers   
OMHE / 
OILS-CA / 
OGN / 
Last updated: Thursday 28th March 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

ATXI Income Statement

Annual
Invalid dateDec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Basic EPS from continuing operations-4.65-3.3
Basic EPS total-4.65-3.3
Basic weighted shares outstanding442329.0682611.01 M1 M1 M2 M
Diluted EPS total-27.75-31.5-24.75-4.65-3.3
Diluted normalized net income/share-24.75-3.3
Diluted weighted shares outstanding65666.091642.01 M1 M1 M2 M
GeneralAndAdministrativeExpense4 M4 M3 M2 M2 M5 M
Income before tax-12 M-22 M-26 M-5 M-4 M-2 M
Income restructuring and M&A-10 M
Interest income88000.093000.0357000.062000.07000.020000.0
InterestExpenseNonOperating375000.0
MinorityInterests3 M51000.0
MiscOtherSpecialCharges-451000.0175000.06 M
Net income from total operations-12 M-22 M-26 M-5 M-4 M-4 M
NetIncomeCommonStockholders-12 M-22 M-26 M-5 M-4 M-4 M
NetIncomeContinuousOperations-12 M-22 M-26 M-5 M-4 M-4 M
NetIncomeFromOtherGainsLosses-99000.0-1 M
NetNonOperatingInterestIncomeExpense-287000.093000.0357000.062000.07000.020000.0
Operating income-11 M-22 M-26 M-5 M-4 M-8 M
Operating income before depreciation (EBITDA)-12 M-22 M-26 M-5 M-4 M-2 M
OperatingExpense11 M22 M26 M5 M4 M8 M
Other income net451000.0-175000.0-6 M
OtherGandA4 M4 M3 M2 M2 M5 M
OtherOperatingExpenses-6 M
RentAndLandingFees4 M4 M
Research & development expense8 M18 M22 M3 M1 M3 M
ResearchExpense8 M18 M22 M3 M1 M3 M
RestructringAndMnAIncome-10 M
Revenue per share-174000.0
SalariesAndWages-604000.0-2 M1000000.0710000.0442000.0649000.0
Selling Gen & administrative expense4 M4 M3 M2 M2 M5 M
Special income/charges10 M
Total Income available for interest expense (EBIT)-12 M-22 M-26 M-5 M-4 M-2 M
Total common shares outstanding685138.01 M1 M1 M1 M6 M
Total net income-12 M-22 M-26 M-5 M-4 M-4 M
Total ordinary shares13 M13 M13 M13 M13 M13 M
TotalExpenses11 M22 M26 M5 M4 M8 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University